Selected aspects of patients' functioning before and after desensitization with specific allergen immunotherapy

被引:0
|
作者
Kawalec-Kajstura, Ewa [1 ]
Chomicka, Magdalena [2 ]
Sulkowska, Joanna [1 ]
Puto, Graiyna [3 ]
Kuzmicz, Ilona [1 ]
机构
[1] Jagiellonian Univ, Fac Hlth Sci, Inst Nursing & Midwifery, Dept Internal Med & Community Nursing,Med Coll JU, Krakow, Poland
[2] Jagiellonian Univ, Fac Hlth Sci, Med Coll JU MC, Krakow, Poland
[3] Jagiellonian Univ, Fac Hlth Sci, Inst Nursing & Midwifery, Dept Clin Nursing,Med Coll JU MC, Krakow, Poland
来源
PIELEGNIARSTWO XXI WIEKU-NURSING IN THE 21 CENTURY | 2019年 / 18卷 / 04期
关键词
allergy; quality of life; specific allergen immunotherapy;
D O I
10.2478/pielxxiw-2019-0033
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Introduction. Allergic diseases belong to the most important health problems responsible for the incidence of various types of discomfort. The application of specific allergen therapy (SAI) is becoming a more and more frequent method aimed at treating allergic diseases. However, this approach requires a strict adherence to medical treatment, which may affect patients'quality of life. Aim. Assessment of quality of life and everyday functioning in the group of patients who underwent a specific allergen therapy. Material and methods. The study group consisted of 80 adult patients who decided to undergo SAI treatment and were treated in two health care facilities in Matopolska region. The study included an assessment of life quality and selected aspects of functioning (as well as their retrospective assessment). As far as the applied methods are concerned, the study was based on the authors' own questionnaire and an abbreviated version of the World Organization Quality of Life-BREF questionnaire. Results. SAI treatment made it possible to reduce both the incidence (Me=4.00 to 2.00; p<0.001) and intensity (Me=4.00 to 2.00; p<0.001) of allergic symptoms. Also the discomfort caused by the allergy was decreased (Me=4.00 to 2.00; p<0.001). Moreover, some improvement in general well-being (Me=4.00 to 5.00; p<0.001) and life satisfaction (Me=4.00 to 5.00; p<0.001) was observed. Conclusions. Specific allergen immunotherapy seems to be worth considering as it improves patients' life satisfaction and reduces discomfort caused by the allergy itself.
引用
收藏
页码:201 / 206
页数:6
相关论文
共 50 条
  • [31] Immunological changes during allergen-specific immunotherapy of atopic patients
    Petrunov, B.
    Nikolov, G.
    Michova, A.
    Radenkova-Saeva, J.
    Taskov, H.
    ADVANCES IN RESEARCH & MANAGEMENT OF ASTHMA AND COPD, 2008, : 35 - +
  • [32] Quality of life of patients undergoing specific allergen immunotherapy in allergic rhinitis
    Brodowicz-Krol, Magdalena
    Guz, Ewa
    Hawryluk, Dorota
    Kulbaka, Ewa
    Panasiuk, Lech
    Lutomski, Piotr
    Kaczor-Szkodny, Paulina
    Choina, Piotr
    ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE, 2020, 27 (04) : 657 - 663
  • [33] MONITORING OF ALLERGEN SPECIFIC IGG AND IGG SUBCLASSES IN PATIENTS UNDERGOING IMMUNOTHERAPY (IT)
    LOFKVIST, T
    SVENSSON, G
    AGRELL, B
    DREBORG, S
    EINARSSON, R
    HAMMARSTROM, L
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1988, 81 (01) : 293 - 293
  • [34] Patients mobile monitoring for an appropriate choice of allergen-specific immunotherapy
    Bianchi, A.
    Gabrielli, F.
    Businco, Di Rienzo A.
    Sfika, I
    Pelosi, S.
    Matricardi, P.
    Tripodi, S.
    ALLERGY, 2015, 70 : 630 - 631
  • [35] Allergen induced cytokine profiles in type I allergic individuals before and after immunotherapy
    Soderlund, A
    Gabrielsson, S
    Paulie, S
    Hammarstrom, ML
    Rak, S
    TroyeBlomberg, M
    IMMUNOLOGY LETTERS, 1997, 57 (1-3) : 177 - 181
  • [36] C5a levels before and after specific immunotherapy in the patients with allergic bronchial asthma
    Inal, A
    Keskin, G
    Musabak, U
    Pekel, A
    Ersoy, F
    ALLERGY, 2002, 57 : 60 - 60
  • [37] Changes in the perception of allergen, its avoidance, and immunotherapy after skin prick test/intradermal test, nasal provocation test, and allergen specific intralymphatic immunotherapy in patients with allergic rhinitis
    Pyo, Sang L.
    Leo, S. M.
    ALLERGY, 2015, 70 : 463 - 464
  • [38] Upregulated levels of human -defensins in patients with seasonal allergic rhinitis after allergen-specific immunotherapy treatment
    Bogefors, Jesper
    Kvarnhammar, Anne Mansson
    Cardell, Lars-Olaf
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2013, 3 (02) : 99 - 103
  • [39] MODULATION OF ALLERGEN SPECIFIC IGE AND IGG4 RESPONSES AFTER SUBLINGUAL IMMUNOTHERAPY IN RESPIRATORY ALLERGIC PATIENTS
    Titov, L.
    Maslova, L.
    DuBuske, L.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S40 - S40
  • [40] Evaluation of the quality of life in patients affected by nickel sulphate system allergy (SNAS) before and after specific desensitization
    Di Rienzo, A.
    Nucera, E.
    Ricci, A. G.
    Buonomo, A.
    Aruanno, A.
    Mezzacappa, S.
    Centrone, M.
    Schiavino, D.
    ALLERGY, 2018, 73 : 842 - 843